According to Stat News, on May 5, 2022, The J&J adenovirus Covid vaccine "Was limited to people 18 and older who cannot take one of the other available vaccines for medical reasons, or who simply will not agree to be vaccinated with one of the messenger RNA vaccines made by Moderna and by Pfizer and its partner BioNTech."
Peter Marks, the FDA's vaccines lead, told STAT the agency reached its decision after a recent review of the data on the vaccine revealed another person in this country had died after receiving it - the ninth such death - in the first quarter of the year.
"If we see deaths and there is an alternative vaccine that is not associated with deaths but is associated with similar efficacywe felt it was time at this point to make a statement on the fact sheet that this was not a first-line vaccine," said Marks.
Compared to "An alternative vaccine that is not associated with deaths" - a statement made on May 5, 2022.
A document dated FEBRUARY 28, 2021, recently brought to my attention by a Brownstone reader, presents an analysis of "Post-authorization adverse event reports" on the BioNTech/Pfizer Covid vaccine, as requested by the FDA for Pfizer/BioNTech's Biologics License Application.
The "Alternatives" were supposedly "Not associated with deaths." But a report after just 3 months of the initial authorization of one of the two main alternatives shows OVER ONE THOUSAND deaths.
I believe the BioNTech and Moderna Covid mRNA vaccines were predetermined as the only Covid vaccine products that would be not just aggressively marketed by the public health and regulatory bodies themselves, but also the only products that would remain on the market regardless of any reported adverse events, including thousands of deaths.
No comments:
Post a Comment